Live Breaking News & Updates on Atientview Has Been Collecting Datafrom Respondent Patient Groups Globally On The Reputational Status Of Pharmaceutical Industry And Individual Companies Latest Survey Was Conducted Between November 2021 February 2022 For Third Year Ina Row

Stay updated with breaking news from Atientview has been collecting datafrom respondent patient groups globally on the reputational status of pharmaceutical industry and individual companies latest survey was conducted between november 2021 february 2022 for third year ina row. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GILEAD SCIENCES CELEBRATES TOP RANKING BY HEPATITIS & ASIAN PATIENT GROUPS

In the recently published PatientView report, Gilead is ranked number one in all corporate reputation indicators by hepatitis patient groups globally Gilead also ranks first among peers in Asia by patient groups in this region HONG KONG, Sept. 15, 2022 /PRNewswire/ Gilead Sciences, Inc. ranks first among peers for overall corporate reputation, according to 300 Asian patient groups and 111 hepatitis patient groups in the 2021 PatientView Corporate Reputation of Pharma survey. This recognition is testament to Gilead's strong focus on patient centricity and deep commitment to working with patient groups to enhance the quality of care for communities across the world. "This is a remarkable achievement for Gilead and it is heartening to know that patient groups rate us highly in all areas - seeing us as the partner of choice," said Dustin Haines, Vice President & General Manager, Asia 5, Gilead Sciences. "We put patients at the heart of everything we do, and ....

United States , Foster City , Asia Pacific Rainbow , Dustin Haines , Gilead Sciences , Gilead Sciences Inc , View Corporate Reputation , Vice President , General Manager , Asia Pacific Rainbow Grant , N The Recently Published Patientview Report , Ilead Is Ranked Number One In All Corporate Reputation Indicators By Hepatitis Patient Groups Globally Gilead Also Ranks First Among Peers Asia This Region Hong Kong , Sept 15 , 022 Prnewswire Gilead Sciences , Nc Ranks First Among Peers For Overall Corporate Reputation , Ccording To 300 Asian Patient Groups And 111 Hepatitis In The 2021 Patientview Corporate Reputation Of Pharma Survey This Recognition Is Testament Gilead 39s Strong Focus On Centricity Deep Commitment Working With Enhance Quality Care For Communities Across World Quot Isa Remarkable Achievement It Heartening Know That Rate Us Highly All Areas Seeing As Partner Choice , Uot Said Dustin Haines , Ice President Amp General Manager , Asia 5 , Ilead Sciences Quot We Put Patients At The Heart Of Everything Do , Nd This Is What Drives Our Deep Engagement And Collaboration With Diverse Patient Community Based Organizations Across Asia All Of Whom Are Dedicated To Supporting People Living Hiv Viral Hepatitis Focus On Centricity Key The Delivery High Quality Care , Hich We Strongly Believe Unlocks Better Health Outcomes For All Quot Since 2010 , Atientview Has Been Collecting Datafrom Respondent Patient Groups Globally On The Reputational Status Of Pharmaceutical Industry And Individual Companies Latest Survey Was Conducted Between November 2021 February 2022 For Third Year Ina Row , Ilead Placed First In The Survey Conducted With 111 Patient Groups Specializing Either Hepatitis Or Liver Conditions , Hich Had Collectively Been In Communication With 1 8 Million Patients Gilead Topped All Ten Corporate Reputation Indicators , Emonstrating Its Unparalleled Strengths In Educating ,